Investments (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Marketable Equity Securities

Marketable equity securities as of March 31, 2023 and December 31, 2022 are as follows:

	Cost		Cost of Shares Sold			Gross Unrealized Gain (Loss)			Fair Value
Marketable equity securities, March 31, 2023	$	4,290	$	-		$	5,790		$	10,080
Marketable equity securities, December 31, 2022	$	2,976,933	$	(2,915,813	)	$	(56,830	)	$	4,290

Schedule of Short-term Investment

Short-term investments in convertible debt securities consist of the following:

	March 31, 2023		December 31, 2022		March 31, 2022
Convertible note	$	-	$	-	$	845,424
End of period	$	-	$	-	$	845,424
	March 31, 2023				March 31, 2022
Beginning of year	$	-			$	539,351
Investment in convertible debt security		-				-
Accrued interest income on convertible debt security		-				17,753
Convertible debt and interest converted into marketable shares		-				-
Unrealized gain on convertible debt security		-				288,320
End of period	$	-			$	845,424

Long-term Investments

Schedule of Notes Receivable

	March 31, 2023			December 31, 2022		March 31, 2022
Notes receivable from Seastar Medical Holding Corporation (formerly LMAO)	$	2,216,649		$	3,807,749	$	310,000
End of period	$	2,216,649		$	3,807,749	$	310,000
	March 31, 2023					March 31, 2022
Beginning of year	$	3,807,749				$	-
Investment (repayment) in Seastar Medical Holding Corporation notes receivable (formerly LMAO)		(1,644,834	)				310,000
Accrued interest income		53,734					-
End of period	$	2,216,649				$	310,000

Schedule of Long-term Investment - Debt Securities

The Company determined the warrants to have a nominal value due to lack of marketability and Symbionts filing of bankruptcy in December 2022.

	March 31, 2023		December 31, 2022		March 31, 2022
Symbiont.IO Note Receivable	$	1,350,000	$	1,350,000	$	2,106,082
End of period	$	1,350,000	$	1,350,000	$	2,106,082
	March 31, 2023				March 31, 2022
Beginning of year	$	1,350,000			$	2,027,178
Accrued interest income on debt securities		-				78,904
Accrued recovery of legal fees		-				-
Allowance for losses on debt security		-				-
End of period	$	1,350,000			$	2,106,082

Schedule of Long-term Investment - Equity Securities

Long-term investments for the SeaStar (formerly LMAO) warrants consist of the following:

	March 31, 2023			December 31, 2022		March 31, 2022
Seastar Medical Holding Corporation (formerly LMAO) warrants	$	437,924		$	464,778	$	949,754
End of period	$	437,924		$	464,778	$	949,754
	March 31, 2023					March 31, 2022
Beginning of year	$	464,778				$	1,973,413
Investments in equity securities		-					-
Unrealized loss on equity securities		(26,854	)				(1,023,659	)
End of period	$	437,924				$	949,754

Summary of Investment in Unconsolidated Affiliates

Long-term investments for the SeaStar (formerly LMAO) common stock consist of the following:

	March 31, 2023			December 31, 2022		March 31, 2022
Seastar Medical Holding Corporation common stock	$	4,812,750		$	10,608,750	$	-
Investment in unconsolidated affiliate		-			-		4,713,390
End of period	$	4,812,750		$	10,608,750	$	4,713,390
	March 31, 2023					March 31, 2022
Beginning of year	$	10,608,750				$	4,676,130
Unrealized gain (loss) on equity investment		(5,796,000	)				37,260
End of period	$	4,812,750				$	4,713,390